Double Award Winner! Leading The Way in Innovative Equipment
In the wave of medical innovation, WeMed Medical is emerging with excellence and becoming the focus of the industry. Recently, the 2025 Future Medical Top 100 series list was announced. WeMed Medical won the "China Innovative Equipment and Intelligent Manufacturing List TOP100 award", and We Robot+DSA also won the "Best Intelligent Medical Equipment Technology Innovation Product", winning two awards with strength!
The Future Healthcare Top 100 selection is considered one of the authoritative evaluation systems in the field of medical and health innovation in China. By building authoritative, objective and fair valuation evaluation standards and innovation assessment systems, it discovers and commends Chinese innovation pioneers who lead the development trend of the future medical and health industry.
It is no coincidence that Robot+DSA stood out in such a highly anticipated selection. It is undoubtedly one of the key highlights of the award. This innovative product represents the advanced level of current intelligent medical devices. In traditional interventional surgery, doctors need to be exposed to X-ray radiation for a long time, and slight hand shaking may affect the precise placement of vascular stents. Complex cases test the surgeon's physical strength and experience limits. We Robot DSA, an interventional robot developed by WeMed Medical, takes the "Eye-Hand-Brain" collaborative intervention solution as its core, and builds an innovative system covering the entire process of imaging, operation, and decision-making. It completely changes this dilemma with its "sub-millimeter" operation accuracy and "zero radiation" surgical environment.
It is like a doctor's assistant with a "super-stable robotic arm" and an "AI brain". It can complete cross-regional surgeries through 5G remote control, allowing patients in remote areas to enjoy top expert resources; intelligent bionic technology can deeply learn and imitate the techniques of experts during surgery, making surgical operations simple and standardized; the unique force feedback system has a minimum force perception accuracy of 0.01N, which can simulate the touch of real surgery, allowing doctors to "know what is going on" while operating remotely. It is worth mentioning that it is also the world's first domestically produced interventional robot with force feedback function to be launched on the market.
Clinical data is the best proof of technical strength. In hundreds of clinical trials completed by We Robot DSA in multiple tertiary hospitals. The surgical success rate was as high as 100%, the incidence of major adverse cardiovascular events (MACE) within 30 days after surgery was 0. And the proportion of medium and high difficulty surgeries was nearly 90%, covering complex lesion treatment, precise stent placement and other advanced procedures, truly realizing the medical vision of "zero radiation, zero error, and zero fatigue".
Standing at the forefront of the "14th Five-Year Plan" medical equipment industry planning, WeMed Medical's double awards come at the right time. We Robot DSA won the annual intelligent technology innovation product, which not only represents that the "bottleneck" high-end medical technology is being broken one by one by China's smart manufacturing, but also shows that domestic high-end medical equipment is leading the international development with "AI+interventional robots".
